β Home
βΉοΈ Info
π§Ύ At a Glance π Core Facts ποΈ Products/Services β Ratings π§βπΌ Executives π¬ My Commentsπ‘ Analytics
π Insights (2) π’ Company Q&A (663) π οΈ Industry Q&A (164) π Competitors π Price Low π Price Swings β‘ SWOT ποΈ PEST π Porter's Five Forces β¨ Score Positive β οΈ Risk Assessment π§© Segmentation π Ά Google Linksπ Ratios
π° Margins π Financial Ratios π± Growth π Enterprise Value π Key Metrics π΅ Dividendsπ§ Tools
β Due Diligenceπ₯ Video Insights
Universal Corporation has slipped to about $43.30, near its 52-week low of $43.07. The decline reflects a deterioration in recent earnings rather than a collapse in revenue. Fiscal 2026 revenue fell 1% to $2.92 billion, but adjusted earnings per share dropped 43% to $2.64. Gross margin declined to 17.5%, while inventory write-downs and a $41.1 million goodwill impairment pushed reported earnings per share down to $1.30. The pressure continued in fiscal 2027. First-quarter revenue fell 12%, operating income plunged 93%, and Universal reported a $0.20 loss per share. Oversupply in several tobacco categories is hurting volumes, pricing and margins. Yet the valuation has a compelling feature: the company raised its quarterly dividend to $0.83, marking 56 consecutive years of dividend growth. The annualized dividend is $3.32, implying a yield above 7.5% around the current price. The value case depends on normalization of tobacco inventories, margin recovery and stronger execution in Ingredients. The main risks are prolonged oversupply, weak demand, further write-downs and dividend coverage becoming stretched. A recovery is possible if profitability rebounds, but near-term earnings visibility remains limited. This review is for informational and educational purposes only, not financial advice.
